Rademikibart in prefilled syringe
CBP-201-207
Phase 2 other active
Quick answer
Rademikibart in prefilled syringe for COPD Acute Exacerbation is a Phase 2 program (other) at Connect Biopharma Holdings Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Connect Biopharma Holdings Ltd
- Indication
- COPD Acute Exacerbation
- Phase
- Phase 2
- Modality
- other
- Status
- active